We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix,  Inc

Download Mobile App


ATTENTION: Due to the CORONAVIRUS EPIDEMIC, certain events are being rescheduled for a later date or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
06 May 2020 - 09 May 2020

Smart Insulin Patch Automatically Manages Glucose Levels

By HospiMedica International staff writers
Posted on 19 Feb 2020
Print article
Image: An adhesive patch loaded with insulin can help control glucose levels. (Photo courtesy of Zhen Gu/ UNC)
Image: An adhesive patch loaded with insulin can help control glucose levels. (Photo courtesy of Zhen Gu/ UNC)
A single use, removable transdermal patch bearing microneedles loaded with insulin can help monitor and manage glucose levels in diabetics, according to a new study.

Developed at the University of North Carolina (UNC, Chapel Hill, USA), the University of California, Los Angeles (UCLA; USA), and other institutions, the adhesive patch is made of glucose-responsive polymeric matrix, fabricated using photo-polymerization, which incorporates tiny microneedles (less than one mm long) that are pre-loaded with insulin. Once applied, the microneedles penetrate about one half millimeter below the skin, enough to sense blood sugar levels. In studies to test blood glucose regulation in insulin-deficient diabetic mice and mini-pigs, a one quarter-sized patch successfully controlled glucose levels for about 20 hours.

The patch works due to multiple phenylboronic acid units within the polymeric matrix that reversibly form glucose–boronate complexes that due to their increased negative charge, induce the swelling of the polymeric matrix and weaken the electrostatic interactions between the negatively charged insulin and polymers, thus promoting the rapid release of insulin. If the matrix senses glucose levels going up, the polymer is triggered to release insulin; when blood sugar eventually returns to normal, the patch’s insulin delivery also slows down. The study was published on February 3, 2020, in Nature Biomedical Engineering.

“Our main goal is to enhance health and improve the quality of life for people who have diabetes,” said senior author biomedical engineer Professor Zhen Gu, PhD, of UCLA. “This smart patch takes away the need to constantly check one’s blood sugar and then inject insulin if and when it’s needed. It mimics the regulatory function of the pancreas, but in a way that’s easy to use.”

Insulin is a peptide hormone is naturally produced by β cells of the pancreatic islets. It is important for the metabolism of carbohydrates, fats, and protein by promoting the absorption of glucose from the blood. Type 1 diabetes (T1D) occurs when a person’s body does not naturally produce insulin. Type 2 diabetes (T2D) occurs when the body does not efficiently use the insulin that is produced. In either case, a regular dosage of insulin is prescribed to manage the disease, which affects more than 400 million people worldwide.

Related Links:
University of North Carolina
University of California, Los Angeles

Print article



view channel

Surgical Robots Market to Reach USD 13.1 Billion by 2027 Due to High Acceptance in Emerging Regions

The global surgical robots market is forecasted to reach USD 13.1 billion by 2027, driven mainly by low turn-around times and increased innovation in robotics over the coming years. Surgical robots are... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.